18F-FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer and as a Predictor of Lymph Node Involvement
Journal of Clinical Medicine · 17.02.2025 · 14 (4) · 1324
DOI: 10.3390/jcm14041324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.02.2025. Verfasst von Nathalie Viohl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Nuclear Medicine, Jena University Hospital, 07743 Jena, Germany. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Open Access Publication Fund of the Thueringer Universitaets-und Landesbibliothek Jena.
Abstract (Originalsprache)
Background/Objectives: The aim of this study was to evaluate the efficacy and accuracy of PET imaging and performance in defining the preoperative TNM classification, especially the intrathoracic lymph node staging, of patients with lung cancer.
Methods
A retrospective, single-institution study of consecutive patients with surgical therapy of lung cancer that were undergoing preoperative PET/CT scanning at the same center was conducted. A total of 104 patients were included. All patients underwent surgical evaluation with mediastinal and hilar lymph node sampling. Five patients with preoperative suspicion of N3 nodal status who were only tested for N2 were excluded from the observations and analyses of nodal status.
Results
PET/CT staged the nodal status correctly in 85 out of 99 patients (85.9%); overstaging occurred in 7 patients (7.1%) and understaging in 7 patients (7.1%). The overall prevalence of lymph node metastases was 42.3%. When preoperative T classification was compared with postoperative histopathological T classification, 75% patients were correctly staged, 13.5% were overstaged, and 11.5% were understaged by PET/CT. In univariate analysis, lymph node involvement was significantly associated (p < 0.05) with the following primary tumor characteristics: increasing diameter (>35 mm), a maximum standardized uptake value > 9.5, and higher grading. The tumor diameter and the degree of differentiation were found to be factors influencing the SUVmax of the primary tumor as well.
Conclusions
Our data show that integrated PET/CT provides high accuracy in the intrathoracic nodal staging and tumor expansion of lung cancer patients and emphasizes the continued need for surgical staging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Nuclear Medicine, Jena University Hospital, 07743 Jena, Germany.
- Clinic of Thoracic Surgery, Leipzig University Hospital, 04103 Leipzig, Germany.
ORCID-Profile: Martin Freesmeyer, Christian Kühnel
Förderung
- German Research Foundation
- Open Access Publication Fund of the Thueringer Universitaets-und Landesbibliothek Jena
Zitieren
APA
Viohl, N., Steinert, M., Freesmeyer, M., Kühnel, C., & Drescher, R. (2025). 18F-FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer and as a Predictor of Lymph Node Involvement. Journal of Clinical Medicine, 14(4), 1324. https://doi.org/10.3390/jcm14041324
Vancouver
Viohl N, Steinert M, Freesmeyer M, Kühnel C, Drescher R. 18F-FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer and as a Predictor of Lymph Node Involvement. Journal of Clinical Medicine. 2025;14(4):1324. doi:10.3390/jcm14041324
BibTeX
@article{Viohl2025,
author = {Viohl, Nathalie and Steinert, Matthias and Freesmeyer, Martin and Kühnel, Christian and Drescher, Robert},
title = {18F-FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer and as a Predictor of Lymph Node Involvement},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1324},
doi = {10.3390/jcm14041324}
}
EUVIMED